845 related articles for article (PubMed ID: 25204288)
1. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
Babu A; Munshi A; Ramesh R
Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
[TBL] [Abstract][Full Text] [Related]
3. RNAi-combined nano-chemotherapeutics to tackle resistant tumors.
Tekade RK; Tekade M; Kesharwani P; D'Emanuele A
Drug Discov Today; 2016 Nov; 21(11):1761-1774. PubMed ID: 27380716
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with si-RNA and Anti-Cancer Drugs.
Kaur K; Rath G; Chandra S; Singh R; Goyal AK
Curr Drug Deliv; 2018; 15(3):300-311. PubMed ID: 28521675
[TBL] [Abstract][Full Text] [Related]
5. The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy.
Khelghati N; Soleimanpour Mokhtarvand J; Mir M; Alemi F; Asemi Z; Sadeghpour A; Maleki M; Samadi Kafil H; Jadidi-Niaragh F; Majidinia M; Yousefi B
Chem Biol Drug Des; 2021 Apr; 97(4):997-1015. PubMed ID: 33458952
[TBL] [Abstract][Full Text] [Related]
6. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.
Xiao B; Ma L; Merlin D
Expert Opin Drug Deliv; 2017 Jan; 14(1):65-73. PubMed ID: 27337289
[TBL] [Abstract][Full Text] [Related]
8. RNAi-based therapeutics and tumor targeted delivery in cancer.
Kara G; Calin GA; Ozpolat B
Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA.
Sun J; Ogunnaike EA; Jiang X; Chen Z
J Mater Chem B; 2021 Sep; 9(36):7302-7317. PubMed ID: 34382987
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy.
Aigner A; Fischer D
Pharmazie; 2016 Jan; 71(1):27-34. PubMed ID: 26867350
[TBL] [Abstract][Full Text] [Related]
11. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers.
Tsouris V; Joo MK; Kim SH; Kwon IC; Won YY
Biotechnol Adv; 2014; 32(5):1037-50. PubMed ID: 24924617
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
13. Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
Chen M; Wang L; Wang F; Li F; Xia W; Gu H; Chen Y
Int J Nanomedicine; 2019; 14():3557-3569. PubMed ID: 31190812
[No Abstract] [Full Text] [Related]
14. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
15. Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer.
Chitkara D; Singh S; Mittal A
Ther Deliv; 2016; 7(4):245-55. PubMed ID: 27010986
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanoemulsions for anti-cancer drug therapy.
Souto EB; Nayak AP; Murthy RS
Pharmazie; 2011 Jul; 66(7):473-8. PubMed ID: 21812320
[TBL] [Abstract][Full Text] [Related]
18. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
Subhan MA; Torchilin VP
Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
[TBL] [Abstract][Full Text] [Related]
19. siRNA and miRNA for the treatment of cancer.
Jankovic R; Radulovic S; Brankovic-Magic M
J BUON; 2009 Sep; 14 Suppl 1():S43-9. PubMed ID: 19785069
[TBL] [Abstract][Full Text] [Related]
20. Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential.
Larsson M; Huang WT; Liu DM; Losic D
Cancer Treat Rev; 2017 Apr; 55():128-135. PubMed ID: 28363142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
